MedTrace Logo

Therapeutic Effects of Berberine in Patients With Type 2 Diabetes

NCT00425009 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2007-01-22

No results posted yet for this study

Summary

The purpose of this study is to determine whether berberine is effective in the treatment of type 2 diabetes.

Conditions

Interventions

DRUG

Berberine

DRUG

Metformin

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Jun Yin, MD, PhD · Department of Endocrinology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Completion
2004-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00425009 on ClinicalTrials.gov